ProPhase Labs Inc
General ticker "PRPH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $13.5M
ProPhase Labs Inc does not follow the US Stock Market performance with the rate: -40.1%.
Estimated limits based on current volatility of 4.9%: low 0.63$, high 0.70$
Factors to consider:
- Current price 70.8% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.17$, 5.20$]
- 2024-12-30 to 2025-12-30 estimated range: [1.84$, 4.31$]
Financial Metrics affecting the PRPH estimates:
- Negative: Non-GAAP EPS, $ of -0.98 <= 0.10
- Negative: Operating profit margin, % of -32.75 <= 1.03
- Negative: Operating cash flow per share per price, % of -12.28 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
Short-term PRPH quotes
Long-term PRPH plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $79.04MM | $122.65MM | $44.38MM |
| Operating Expenses | $69.24MM | $99.05MM | $66.00MM |
| Operating Income | $9.80MM | $23.59MM | $-21.61MM |
| Non-Operating Income | $-4.50MM | $-0.69MM | $-1.19MM |
| Interest Expense | $1.15MM | $0.76MM | $1.27MM |
| R&D Expense | $0.52MM | $0.65MM | $1.42MM |
| Income(Loss) | $5.30MM | $22.91MM | $-22.80MM |
| Taxes | $-0.97MM | $4.45MM | $-6.02MM |
| Profit(Loss) | $6.27MM | $18.46MM | $-16.78MM |
| Stockholders Equity | $58.63MM | $63.63MM | $49.38MM |
| Inventory | $4.60MM | $3.98MM | $3.84MM |
| Assets | $89.30MM | $87.65MM | $91.93MM |
| Operating Cash Flow | $-13.62MM | $28.55MM | $-11.35MM |
| Capital expenditure | $4.23MM | $3.92MM | $3.15MM |
| Investing Cash Flow | $-19.67MM | $-2.08MM | $-1.37MM |
| Financing Cash Flow | $35.13MM | $-26.02MM | $5.76MM |
| Earnings Per Share* | $0.41 | $1.17 | $-0.98 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.